Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5.17	3.69	6.58	25.91	27.33
Cash & Short-Term Investments	5.17	3.69	6.58	25.91	27.33
Cash Growth	39.99%	-43.89%	-74.61%	-5.18%	66.63%
Accounts Receivable	16.07	11.34	13.45	14.17	21.42
Other Receivables	0.52	1.67	2.21	1.54	3.18
Receivables	16.58	13.01	15.66	15.71	24.6
Inventory	19.37	19.93	22.5	29.12	30.22
Prepaid Expenses	-	2.04	1.93	1.95	1.16
Other Current Assets	-	0.37	-	-	-
Total Current Assets	41.12	39.04	46.67	72.69	83.3
Property, Plant & Equipment	4.62	1.89	5.68	5.92	8.55
Goodwill	-	-	12.54	12.54	12.59
Other Intangible Assets	51.34	1.17	5.72	5.77	7.83
Long-Term Accounts Receivable	-	0.04	0.08	0.15	0.29
Long-Term Deferred Tax Assets	3.55	1.98	4.22	4.1	4.18
Long-Term Deferred Charges	-	15.1	17.01	17.68	13.44
Other Long-Term Assets	2.65	0.22	0.18	0.06	0.21
Total Assets	103.29	59.44	92.1	118.9	130.4
Accounts Payable	26.78	3.89	6.21	6.76	7.1
Accrued Expenses	-	8.07	9.06	8.12	9.69
Short-Term Debt	0.21	-	-	0.03	2.91
Current Portion of Long-Term Debt	-	0.21	0.21	83.31	-
Current Portion of Leases	2.29	1.69	1.68	1.98	2.15
Current Income Taxes Payable	0.36	0.28	0.03	0.02	0.15
Current Unearned Revenue	-	0.05	0.11	0.21	4.45
Other Current Liabilities	2.45	0.85	0.05	0.05	0.61
Total Current Liabilities	32.1	15.04	17.34	100.49	27.06
Long-Term Debt	87.79	54.65	58.05	-	82.7
Long-Term Leases	10.48	10.87	12.27	13.87	16.59
Long-Term Deferred Tax Liabilities	4.56	2.3	5.06	4.86	4.91
Other Long-Term Liabilities	3.55	0.53	1.57	-	1.37
Total Liabilities	138.47	83.38	94.28	119.21	132.62
Common Stock	4.19	1.97	1.96	1.21	1.21
Additional Paid-In Capital	63.4	46.62	46.46	16.19	16.19
Retained Earnings	-79.12	-48.64	-26.7	12.56	10.57
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92
Comprehensive Income & Other	1.27	1.03	1.02	-5.36	-5.27
Shareholders' Equity	-35.18	-23.95	-2.18	-0.32	-2.22
Total Liabilities & Equity	103.29	59.44	92.1	118.9	130.4
Total Debt	100.76	67.43	72.2	99.19	104.34
Net Cash (Debt)	-95.6	-63.74	-65.62	-73.28	-77.01
Net Cash Per Share	-144.19	-8.33	-9.73	-17.53	-18.42
Filing Date Shares Outstanding	0.66	9.47	7.64	5.38	4.18
Total Common Shares Outstanding	0.66	7.67	7.62	4.18	4.18
Working Capital	9.03	24.01	29.33	-27.8	56.24
Book Value Per Share	-53.07	-3.12	-0.29	-0.08	-0.53
Tangible Book Value	-86.52	-25.12	-20.44	-18.62	-22.64
Tangible Book Value Per Share	-130.51	-3.28	-2.68	-4.45	-5.41
Land	-	24.27	24.68	24.33	24.29
Machinery	-	39.04	38.22	36.54	38.15
Leasehold Improvements	-	2.76	2.7	2.59	2.67

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q